Integra Lifesciences Holdings Corp (IART)
24.15
+4.87
(+25.26%)
USD |
NASDAQ |
Nov 04, 13:03
Integra Lifesciences Holdings Enterprise Value: 3.024B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 3.024B |
| October 31, 2024 | 2.984B |
| October 30, 2024 | 3.040B |
| October 29, 2024 | 3.041B |
| October 28, 2024 | 3.027B |
| October 25, 2024 | 2.999B |
| October 24, 2024 | 2.993B |
| October 23, 2024 | 3.011B |
| October 22, 2024 | 3.017B |
| October 21, 2024 | 3.042B |
| October 18, 2024 | 3.070B |
| October 17, 2024 | 3.061B |
| October 16, 2024 | 3.064B |
| October 15, 2024 | 3.042B |
| October 14, 2024 | 3.019B |
| October 11, 2024 | 3.020B |
| October 10, 2024 | 3.023B |
| October 09, 2024 | 2.933B |
| October 08, 2024 | 2.885B |
| October 07, 2024 | 2.881B |
| October 04, 2024 | 2.847B |
| October 03, 2024 | 2.843B |
| October 02, 2024 | 2.872B |
| October 01, 2024 | 2.886B |
| September 30, 2024 | 2.938B |
| Date | Value |
|---|---|
| September 27, 2024 | 2.915B |
| September 26, 2024 | 2.884B |
| September 25, 2024 | 2.858B |
| September 24, 2024 | 2.916B |
| September 23, 2024 | 2.889B |
| September 20, 2024 | 2.878B |
| September 19, 2024 | 2.884B |
| September 18, 2024 | 2.888B |
| September 17, 2024 | 2.860B |
| September 16, 2024 | 2.872B |
| September 13, 2024 | 2.884B |
| September 12, 2024 | 2.898B |
| September 11, 2024 | 2.894B |
| September 10, 2024 | 2.903B |
| September 09, 2024 | 2.891B |
| September 06, 2024 | 2.964B |
| September 05, 2024 | 3.017B |
| September 04, 2024 | 3.028B |
| September 03, 2024 | 3.023B |
| August 30, 2024 | 3.106B |
| August 29, 2024 | 3.135B |
| August 28, 2024 | 3.107B |
| August 27, 2024 | 3.120B |
| August 26, 2024 | 3.154B |
| August 23, 2024 | 3.163B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.843B
Minimum
Oct 03 2024
7.711B
Maximum
Apr 27 2021
5.445B
Average
5.529B
Median
Jul 18 2022
Enterprise Value Benchmarks
| Abbott Laboratories | 213.13B |
| Perspective Therapeutics Inc | 524.04M |
| Retractable Technologies Inc | -19.02M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.40M |
| Revenue (Quarterly) | 418.18M |
| Total Expenses (Quarterly) | 421.20M |
| EPS Diluted (Quarterly) | -0.16 |
| Gross Profit Margin (Quarterly) | 54.02% |
| Profit Margin (Quarterly) | -2.97% |
| Earnings Yield | 1.20% |
| Operating Earnings Yield | 3.36% |
| Normalized Earnings Yield | 1.201 |